SCOPUS 정보 검색 플랫폼

Circulation

Volumn 134, Issue 8, 2016, Pages 574-575

Cardioprotection: The disconnect between bench and bedside

(2) Rossello, Xavier a Yellon, Derek M a,b

a UNIVERSITY COLLEGE LONDON (United Kingdom)

b UNIVERSITY COLLEGE LONDON HOSPITALS (United Kingdom)

Author keywords

cytoprotection; myocardial infarction; myocardial reperfusion injury

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; STATIN (PROTEIN); CARDIOTONIC AGENT;

ANTICOAGULATION; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; HEART LEFT VENTRICLE CONTRACTION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; POINT OF CARE SYSTEM; TRENDS;

ANIMALS; CARDIOTONIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; POINT-OF-CARE SYSTEMS; PURINERGIC P2Y RECEPTOR ANTAGONISTS;

EID: 84983607912 PISSN: 00097322 EISSN: 15244539 Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.116.022829 Document Type: Review

Times cited : (48)

References (5)

1
- 37549038706
- Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning
- Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007; 59: 418-458. doi: 10.1124/pr.107.06002
- (2007) Pharmacol Rev , vol.59 , pp. 418-458
- Ferdinandy, P.¹ Schulz, R.² Baxter, G.F.³

2
- 84883236117
- Cardioprotection in the aging, diabetic heart: The loss of protective Akt signalling
- Whittington HJ, Harding I, Stephenson CI, Bell R, Hausenloy DJ, Mocanu MM, Yellon DM. Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res. 2013; 99: 694-704. doi: 10.1093/cvr/cvt140
- (2013) Cardiovasc Res , vol.99 , pp. 694-704
- Whittington, H.J.¹ Harding, I.² Stephenson, C.I.³ Bell, R.⁴ Hausenloy, D.J.⁵ Mocanu, M.M.⁶ Yellon, D.M.⁷

3
- 84873126984
- American college of cardiology foundation/American Heart Association task force on practice guidelines 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: A report of the American college of cardiology foundation/American Heart Association task force on practice guidelines
- O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127: e362-e425. doi: 10.1161/CIR.0b013e3182742cf6
- (2013) Circulation , vol.127 , pp. e362-e425
- O'Gara, P.T.¹ Kushner, F.G.² Ascheim, D.D.³ Casey, D.E.⁴ Chung, M.K.⁵ De Lemos, J.A.⁶ Ettinger, S.M.⁷ Fang, J.C.⁸ Fesmire, F.M.⁹ Franklin, B.A.¹⁰ Granger, C.B.¹¹ Krumholz, H.M.¹² Linderbaum, J.A.¹³ Morrow, D.A.¹⁴ Newby, L.K.¹⁵ Ornato, J.P.¹⁶ Ou, N.¹⁷ Radford, M.J.¹⁸ Tamis-Holland, J.E.¹⁹ Tommaso, C.L.²⁰ more..

4
- 84885172325
- Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart
- Yang XM, Cui L, Alhammouri A, Downey JM, Cohen MV. Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart. Cardiovasc Drugs Ther. 2013; 27: 403-412. doi: 10.1007/s10557-013-6474-9
- (2013) Cardiovasc Drugs Ther , vol.27 , pp. 403-412
- Yang, X.M.¹ Cui, L.² Alhammouri, A.³ Downey, J.M.⁴ Cohen, M.V.⁵

5
- 84878317288
- Platelet P2Y blockers confer direct postconditioning-like protection in reperfused rabbit hearts
- Yang XM, Liu Y, Cui L, Yang X, Liu Y, Tandon N, Kambayashi J, Downey JM, Cohen MV. Platelet P2Y blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J Cardiovasc Pharmacol Ther. 2013; 18: 251-262. doi: 10.1177/1074248412467692
- (2013) J Cardiovasc Pharmacol Ther , vol.18 , pp. 251-262
- Yang, X.M.¹ Liu, Y.² Cui, L.³ Yang, X.⁴ Liu, Y.⁵ Tandon, N.⁶ Kambayashi, J.⁷ Downey, J.M.⁸ Cohen, M.V.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.